SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Boss kick fired employee away form office. concept of lay off or underperform, failure or mistake
Layoffs
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves
The layoffs will not spare Generation’s R&D team, which will initially be retained while the biotech completes its strategic review but will eventually be let go.
August 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out after reportedly sparring with other agency officials over communications strategy; Eli Lilly’s first Phase III readout for oral obesity drug orforglipron missed analyst expectations; and Arrowhead Pharmaceuticals addresses the recent woes of its of partner Sarepta.
August 13, 2025
 · 
2 min read
 · 
Heather McKenzie
Pros and cons collage. Mixed media thumbs up and thumbs down hand gestures with speech bubbles. Review concept, positive and negative feedback vector illustration.
Opinion
The High Stakes Tradeoffs of a Most Favored Nation Drug Policy
President Donald Trump loves a deal, but Most Favored Nation drug pricing isn’t a good one for anyone.
August 13, 2025
 · 
3 min read
 · 
Fred Roeder
Creative photo collage or modern art collage featuring symbols of law and justice. Hand holding a gavel and scales of justice with books about law.
Legal
Texas Accuses Lilly of ‘Bribing’ Prescribers To Push Mounjaro, Zepbound in New Suit
Texas Attorney General Ken Paxton claims that through an alleged kickback scheme Eli Lilly “fraudulently sought to maximize profits at taxpayer expense.”
August 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Approvals
Insmed Wins Approval for First Bronchiectasis Drug and DPP1 Blocker
Insmed’s Brinsupri is the first DPP1 inhibitor approved by the FDA and the first treatment for bronchiectasis to reach the market.
August 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Retro collage hand holding pie chart diagram. Business data and market share concept. Modern retro grunge. Vector illustration
Gene therapy
Sarepta Provides New Elevidys Safety Data, Reveals Zero Ambulatory Deaths
Jefferies analysts said these detailed safety outcomes confirm the gene therapy’s positive risk/benefit profile in ambulatory patients with Duchenne muscular dystrophy.
August 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing hand/puppeteer controlling falling businessman
Career Advice
Loyalty Is a Flawed Strategy—And It Can Cost You
What if loyalty is holding you back? While it’s a sign of character, consistency and belief in a mission bigger than yourself, it can also keep you stuck in a job when you should be moving on.
August 13, 2025
 · 
4 min read
 · 
Angela Justice
concept of a perilous situation with a man who finds himself suspended above the void while standing at the edge of the cliffs.
GLP-1
A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma recover?
August 13, 2025
 · 
5 min read
 · 
Nick Paul Taylor
Robotic Claw grab money from a pile of money and bomb.take risk. Grip robotic claw in factory. claw Arcade game put money and coin.claw game device. toy cranes claw machine.
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
August 13, 2025
 · 
4 min read
 · 
Annalee Armstrong
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS